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Summary
To identify interleukin-10 (IL-10)-producing cells in
vivo, we generated a knockin mouse where an internal
ribosome entry site (IRES) green fluorescence protein
(GFP) element was inserted immediately before the
polyadenylation site of the IL-10 gene. GFP fluores-
cence in cells from these mice was found to correlate
positively with IL-10 protein expression. With this
model, we found that after multiple T cell receptor
(TCR) stimulations, strong expression of IL-10 was
produced specifically by intraepithelial lymphocytes
(IEL) in the small intestine and colonic lamina propria
lymphocytes (cLPL). We found that anti-CD3 treatment
induces T regulatory cell 1 (Tr1)-like cells in small intes-
tinal IEL (sIEL) and led to the accumulation of naturally
occurring regulatory T (nTreg) cells in colonic LPL
(cLPL). These findings highlight the intestine as a
unique site for induction of IL-10-producing T cells,
which play a critical role in the regulation of inflamma-
tion in the gut.
Introduction
Understanding how the immune system is controlled
to avoid tissue destruction and other adverse effects
caused by immunopathology associated with infection,
autoimmune diseases, and allergy should provide an
explanation for the etiology of such abnormalities and
may lead to more effective treatment of disease.
One of the key molecules highly associated with im-
munological tolerance and suppression is interleukin-
10 (IL-10). High serum IL-10 has been observed to corre-
late with remission of several diseases, especially those
in which induction of immunological tolerance is critical.
Understanding the mechanism by which IL-10 regulates
the immune system might therefore yield a method for
effective control of immunity by clinical intervention.
Because the most prominent phenotype observed in
IL-10-deficient mice is inflammation in the intestine,
IL-10 might be important in regulating inflammatory
response in the intestine. Indeed, the importance of
IL-10 in tolerance was demonstrated by the adoptive
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munodeficient mice, which showed that IL-10 has a role
in disease suppression (Asseman et al., 1999; Powrie
et al., 1994). Given that intestinal organs have been
reported to express IL-10 abundantly (Autschbach
et al., 1998; Braunstein et al., 1997), it is necessary to
analyze which cells express IL-10 in mucosal tissue.
Such information might in turn lead to the understanding
of the immunological regulation in intestine.
In the literature, a wide variety of cells have been re-
ported to express IL-10 in vitro, including T helper 2
(Th2) cells, B cells, macrophages, and NKT cells, Th3
cells, CD4+CD25+ naturally occurring regulatory T cells
(nTreg), T regulatory cell 1 (Tr1) (reviewed in Moore
et al., 2001), and IEL (Das et al., 2003). Similarly, recep-
tors for IL-10, IL-10R1, and IL-10R2 are also expressed
on many cell types (Moore et al., 2001) and are often ob-
served in IL-10-expressing cells, which suggests that the
IL-10 producers themselves can also be targets. The
multitude of possible IL-10 producers as well as targets
underscores the importance of identifying which cells
produce substantial amounts of this cytokine and which
cells receive the signal in vivo.
Unfortunately, IL-10 detection is difficult, especially in
vivo, because of its short half-life and rapid secretion.
Although it is possible to stimulate cells ex vivo and
detect the cytokine in supernatants or to analyze IL-10
intracellular staining by flow cytometry, it is not simple
to correlate which positively stained cells provide the
secreted IL-10. Furthermore, the signals obtained by
intracellular staining are often too weak to identify the
IL-10-producing cells in vivo.
Here, we show that the green fluorescence protein
(GFP) knockin mouse, designated tiger (interleukin-ten
ires gfp-enhanced reporter), provides a valuable tool
for IL-10 analysis and that multiple rounds of TCR stimu-
lation generated cells highly committed to produce IL-10
in vivo. Interestingly, these cells could be found prefer-
entially in the intestine, in particular, IEL in the small in-
testine and LPL in the colon. The findings presented
here implicate the intestine as a unique microenviron-
ment for the development of and stimulus for IL-10-
producing cells in vivo. By combining our previously
described forkhead box P3 (Foxp3) knockin mice with
the tiger mice, we characterized the relationship of
Foxp3 and IL-10 expression in the intestine and analyzed
IL-10-GFP expression in models of infection.
Results
Generation of tiger Mice
We generated a GFP knockin targeting vector (Figure 1A,
middle) designed to undergo integration into the Il10
locus (Figure 1A, top) by homologous recombination.
The neo resistant gene was inserted at the end of the
last exon not affecting the 30-untranslated region. After
successful electroporation and integration of the con-
struct into embryonic stem (ES) cells, Cre-mediated
excision of neomycin was performed to yield the mutant
allele (Figure 1A, bottom) by direct transfection of Cre
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(A) A 9.6 kb genomic fragment of the IL10 locus (top) was used to create the targeting vector (middle), into which an IRES-GFP cassette followed
by a LoxP-flanked neomycin resistance gene was inserted between the stop codon and polyadenylation signal of exon 5. Deletion of neo by Cre
recombinase resulted in the final mutant allele (bottom). Abbreviations: tk, thymidine kinase; B, BamHI; H, HindIII.
(B) Genotyping of tiger mice by PCR.
(C) FACS histograms of GFP profile of Th2 cells from control (no fill, foreground), heterozygous (light gray fill, middle), and homozygous (dark gray
fill, background) tiger mice.
(D) Supernatants from the cultures described in the preceding panel at the time points indicated without restimulation of cells. Open, gray, and
closed boxes show the concentration of IL-10 in wild-type, heterozygous, and tiger/tiger homozygous Th2 cell supernatants, respectively. The
error bars show the standard deviation.
(E) Dot plots of PE-anti-IL-10 (vertical axis) versus GFP (horizontal axis) intracellular staining obtained from wild-type (left), heterozygous
(middle), and homozygous (right) mice.
(F) Quantitative analysis of mRNA in GFPhi and GFPlo population of Th2 cells. The Th2 cells were differentiated in vitro and were FACS sorted as
shown at left. Total RNA from the GFPhi cells and GFPlo cells were obtained and analyzed for IL-10 mRNA by the quantitative PCR. The data
shown are the typical results from more than three experiments. The error bars show the standard deviation.recombinase into positively selected ES cell clones,
which were then injected into C57BL/6 blastocysts. Chi-
meric males were bred to C57BL/6 mice, and subse-
quent generations were bred to hetero- or homozygosity
as experiments warranted. The resulting mice were via-
ble and fertile, showing no gross phenotypic defects.
At no time did any mouse develop inflammatory bowel
disease, confirming that endogenous regulation of IL10
production remained intact. We have designated these
animals tiger mice.
GFP Expression of tiger Th2 Cells
In order to validate IL-10 production and GFP expres-
sion, CD4+ splenocytes from C57BL/6 and heterozygous
and homozygous tiger mice were stimulated under Th0,
Th1, and Th2 conditions. We could detect neither GFP
nor IL-10 production in cells developed under Th0 or
Th1 conditions (fewer than 1% positive cells), so we
focused on IL-10 and GFP expression in Th2 cells. 1.5,
2.5, and 5.5 days after initiation of Th2 cultures, cellsand supernatants were analyzed by flow cytometry and
enzyme-linked immunosorbent assay (ELISA). The histo-
grams in Figure 1C show an increasingly robust and
distinct GFP+ population over time. Further, the amount
of IL-10 cytokine produced, as measured by ELISA
(Figure 1D), correlated with the percentage of GFP+ cells.
Finally, IL-10 from both hetero- and homozygous tiger
mice was upregulated to comparable amounts of pro-
duction at the same kinetics as that of control mice. Inter-
estingly, the mean fluorescent intensity (MFI) of cells
from heterozygous tiger mice was slightly less than
that of their homozygous counterparts (MFI = 46.2 6
2.4 versus 59.26 0.9 for hetero and homo, respectively).
When we stained these cells for intracellular IL-10, we
observed that most of the IL-10-producing cells were
GFP+ and that IL-10 protein positively correlated with
GFP expression. In heterozygous tiger mice, there was
a small percentage of IL-10-positive, GFP-negative cells
(Figure 1E, middle), whereas the corresponding popula-
tion is virtually absent in homozygous mice (Figure 1E,
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ulation in heterozygous mice, IL-10 was possibly tran-
scribed off the wild-type but not the tiger allele. More im-
portantly, the absence of IL-10-positive, GFP-negative
cells in homozygous tiger mice indicates that all IL-10
production is coincident with GFP fluorescence. How-
ever, the fact that more than 50% of Th2 cells in hetero-
zygous mice are double positive for IL-10 and GFP also
suggests that both alleles are transcribed, arguing
against monoallelic transcription of this cytokine.
To confirm that GFP expression reflected the IL-10
mRNA expression, we sorted the GFPhi cells and GFPlo
cells from Th2 cells differentiated in vitro (Figure 1F).
Quantitative PCR results showed more than a 10-fold
difference of IL-10 mRNA expression between GFPhi
and GFPlo cells. This result indicates that, by detecting
GFP expression in cells of tiger mice, we can approxi-
mate the amount of IL-10 mRNA and that this system
is useful as a reporter for IL-10 mRNA production.
GFP Expression in Macrophages and Dendritic Cells
It has been reported that IL-10 is expressed by macro-
phages (Kambayashi et al., 1996) and certain dendritic
cell subsets (Akbari et al., 2001; Iwasaki and Kelsall,
1999). We therefore attempted to detect GFP expression
in these cell types from the tigermouse. In bone marrow-
derived macrophages (BMDM), low basal GFP fluores-
cence could be seen when cells from tiger mice were
cultured in medium alone (Figure 2A, MFI = 3.7 6 0.4).
However, when these macrophages were incubated in
the presence of lipopolysaccaharide (LPS) (Figure 2B,
MFI = 8.2 6 1.2), GFP expression was clearly elevated.
Addition of IL-4 further increased GFP expression in
macrophages (Figure 2C, MFI = 13.2 6 0.3). The GFP
expression correlated with the IL-10 produced in the cul-
ture supernatant (medium < 25 pg/ml, LPS 352 6 20.4
pg/ml, LPS+IL-4 624 6 10.7 pg/ml). This observation
was consistent with previous findings by other groups
(Kambayashi et al., 1996) and shows that GFP expres-
sion associates with conditions under which IL-10 is
produced.
When we obtained BMDC and stimulated them with
LPS, we could not detect any GFP expression (data not
shown). Zymosan, a yeast cell wall component, potently
induces IL-10 in dendritic cells (Rogers et al., 2005), so
we stimulated BMDC with this reagent in the presence
or absence of IL-4, IL-10, or transforming growth
factor-b (TGF-b). As shown in Figure 2E, zymosan in-
duced GFP expression in the tiger BMDC and enhanced
it in the presence of TGF-b (Figure 2F, p < 0.05). Neither
IL-4 nor IL-10 increased the GFP signal (data not shown).
Intracellular staining of dendritic cells confirmed the up-
regulation of GFP expression in IL-10-expressing cells
(Figures 2G and 2H) (although there is substantial auto-
fluorescence of BMDC, we consistently observed upre-
gulation of GFP in IL-10-positive cells in repeated exper-
iments). However, in contrast to the result obtained with
Th2 cells, the upregulation of the GFP in IL-10-producing
cells was relatively low in BMDC. This result might sug-
gest that either the tiger system is less sensitive in mye-
loid cells, perhaps because of the stability of GFP in
these cells, or alternatively that the transcriptional regu-
lation of dendritic cells and T cells might be different.
Both dendritic cells and macrophages produce lessGFP and intracellular IL-10, so IL-10 transcription might
be more strictly regulated. When we recovered dendritic
cells ex vivo from spleen and Peyer’s patches and
stimulate them with zymosan, GFP expression was ob-
served as only a slight shift of the histogram (see Fig-
ure S1 in the Supplemental Data available online), and
there was no GFP high population. Thus, the expression
of IL-10 in DC ex vivo was less than that of BMDC stimu-
lated in vitro.
Taken together, we could confirm that a GFP signal
can be induced in both macrophages and dendritic cells
in response to stimuli that lead to IL-10 production.
Superantigen Stimulation Induces GFP in IEL
and Peyer’s Patch T Cells
To observe which cells express IL-10 in vivo, we ana-
lyzed GFP fluorescence in various cell types from un-
treated tigermice. However, we could not find GFP+ cells
in unstimulated mice except for a slight increase in mes-
enteric lymph nodes (less than 3%) and colonic LPL
(0%–7%) (see below). It is known that IL-10 is readily
detectable in serum upon injection of mice with staphy-
lococcal enterotoxin A (SEA), which stimulates a certain
subset of T cells and subsequently anergizes them
(Miller et al., 1999; Sundstedt et al., 1997); this finding
is particularly visible upon repeated treatment of the
Vb expressing pigeon cytochrome C responsive TCR
Figure 2. GFP Expression in Bone Marrow-Derived Macrophages
and Dendritic Cells
(A–C) Macrophages derived from bone marrow cells were incubated
with (A) medium alone, (B) LPS, or (C) IL-4 and LPS.
(D–F) BMDCs were cultured in the presence of (D) medium alone, (E)
zymosan, or (F) zymosan and TGF-b. Dotted line represents GFP2
control cells and solid line represents cells from tiger mice. Mean
and standard deviation (SD) is shown as ‘‘mean 6 SD.’’ Macro-
phages were gated for CD11b+ and dendritic cells were gated for
CD11c.
(G and H) Intracellular staining of BMDC with anti-IL-10 in (G) wild-
type mice and (H) tiger mice are shown. The data shown are typical
results of five experiments.
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tiger 3 AND TCR Tg mice (solid line) and the non-tiger AND TCR Tg mice (dotted line) were injected with SEA three times.
(A–F) 4 hr after final stimulation, TCRab+ T cells from (A) spleen, (B) mesenteric lymph node, (C) CD11c+ dendritic cells in spleen, (D) TCRab+
lymphocytes in Peyer’s patch, (E) TCRab+ lymphocytes in IEL, and (F) intestinal epithelial cells in small intestine were recovered and expression
of GFP was analyzed. Mean and SD is shown as ‘‘mean 6 SD.’’
(G–Q) tiger mice (solid line) and the non-tiger mice (dotted line) were injected with 20 mg of anti-CD3 three times.
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crossed tiger mice to AND TCR Tg mice. Littermates of
tiger allele-negative, AND TCR transgene-positive mice
were used as controls.
4 hr after injecting SEA, the GFP expression in cells
from various organs was analyzed by flow cytometry.
To our surprise, despite polyclonal activation in vivo,
these mice showed a relatively low number of GFP+
CD4+ or CD8+ cells from the spleen (Figure 3A) or lymph
node (Figure 3B). However, a high percentage of IEL
were positive for GFP (Figure 3E). In the same experi-
ment, we examined dendritic cells from the spleen and
intestinal epithelial cells, but we could not detect any
GFP signal (Figures 3C and 3F, respectively).
It is also of interest that Peyer’s patches contained
a high number of GFP+ T cells (Figure 3D) after SEA stim-
ulation, whereas mesenteric lymph nodes contained far
fewer GFP+ T cells and in fact more closely resembled
the pattern seen in the spleen (compare Figures 3B ver-
sus 3A). This result underscores the unique ability of the
Peyer’s patch to generate IL-10-expressing T cells.
To summarize, we found in this model of T cell toler-
ance that IL-10 was expressed at the highest amounts
in IEL and Peyer’s patch T cells.
Multiple In Vivo Stimulation with Anti-CD3 Induces
GFP in IEL of tiger Mice
It has previously been shown that repeated in vivo treat-
ment with anti-CD3 yields immune tolerance (Bach and
Chatenoud, 2001). We therefore administered this anti-
body to non-TCR Tg tiger mice to enable detection of
GFP under this tolerogenic protocol and to analyze ex-
actly which cells were associated with this IL-10 expres-
sion. We obtained similar results with anti-CD3 stimula-
tion to those obtained with SEA stimulation in TCR Tg
mice (Figure 3G). Most IEL TCRab cells were GFP+ after
three rounds of stimulation with anti-CD3. Interestingly,
IEL increased their intensity of GFP signal as the fre-
quency of injection increased (Figure 3G). In the same ex-
periment, we examined CD4+ and CD8+ TCRab+ T cells
from spleen (Figures 3H and 3I, respectively) and mesen-
teric lymph nodes (Figures 3J and 3K). The expression
pattern of GFP in these TCRab cells was similar to the
results obtained in tiger 3 AND TCR Tg mice; that is,
they did not show a distinct GFP+ population. In splenic
T cells, we found a similar low frequency of GFP+ cells in
CD4+ and CD8+ T lymphocytes that we observed with
SEA stimulation. This was not caused by a failure to
activate splenic T cells, because most splenic T cells
upregulated CD69 in response to the CD3 stimulus (Fig-
ure S3). In Peyer’s patches, CD4+ T cells expressed sim-
ilar GFP expression to splenic T cells (Figures 3L versus
3H), but CD8+ cells displayed high GFP expression rem-
iniscent of those seen in stimulated IEL (Figures 3M ver-
sus 3G, 4th panel). Thus, based on our results, it appears
that Peyer’s patch CD8+ cells have a greater potential to
become IL-10-producing cells than do CD4+ T cells.However, since 83%–88% of the T cells in Peyer’s
patches are CD4+ CD82 cells, the T cells in this organ as
a whole resembled the spleen in terms of overall GFP
expression pattern after anti-CD3 treatment, a result
that differed from the observations seen in AND TCR
Tg mice stimulated with SEA. It is difficult to interpret
this difference unequivocally, but we believe it might re-
flect the different mode of stimulation in vivo by superan-
tigen versus anti-CD3. Superantigen is known to bind to
the TCR-b chain and MHC class II, where it mimics anti-
gen presentation by APCs; anti-CD3, in contrast, triggers
a TCR signal by binding to cells that express Fc recep-
tors and thereby enable crosslinking of the TCR. The
difference of the distribution of class II molecules and
Fc receptor expression might be responsible for this dif-
ference in GFP expression, which may, for example, re-
quire the involvement of tolerogenic APCs in order for
a T cell to produce IL-10. Indeed, when we stimulated
normal mice with SEA several times, more than 40% of
Vb3+CD4+ T cells in the Peyer’s patch were GFP+. As
we show below that the Fc binding ability is necessary
for the induction of IL-10 expression, this too suggests
the importance of the accessory cells binding to the
anti-CD3.
IEL comprise mainly TCRab cells and TCRgd cells and,
within the TCRab subset, CD8aa and CD8ab cells (Hay-
day et al., 2001). When we viewed each population
separately, we found that TCRab cells were consistently
more GFP+ than gd cells (Figures 3Q and 3P, respec-
tively). Intestinal CD8ab cells are more like conventional
T cells, whereas CD8aa cells reside selectively in the IEL
compartment. When we compared these two types of
IEL, the frequency of GFP+ CD8ab cells was always
higher than that of GFP+ CD8aa cells (Figures 3N and
3O, respectively). This result suggests that conventional
T cells might possess a greater potential to produce
IL-10 in the IEL compartment.
The high expression of GFP in IEL was not dependent
on the site of anti-CD3 administration, because both
intraperitoneal and retro-orbital intravenous injection
gave similar results (data not shown). Taken together,
IEL and certain populations of Peyer’s patch cells spe-
cifically acquire GFP expression and, therefore, IL-10
competence, after multiple rounds of stimulation with
anti-CD3.
GFP Expression in IEL and LPL in the Small Intestine
and the Colon
The major subsets of lymphocytes in the intestine are IEL
and LPL. Furthermore, the lymphocytes in the small
intestine and colon seem to have different characteris-
tics in each compartment (Hayday et al., 2001). To eluci-
date further the differences between each population,
we collected IEL and LPL from the small intestine and
colon to determine IL-10 expression under a variety of
conditions. The majority of TCRab+ IEL in the small
intestine (sIEL) were CD8+ cells (Figure 4A), whereas(G) TCRab IEL were recovered after each injection and detected for GFP expression. The number indicated below each panel shows the number
of injections. 4 hr after the final injection, cells from various organs were recovered and analyzed for GFP expression by flow cytometry.
(H–Q) GFP expression after three anti-CD3 injections. The GFP expression in (H) CD4+ T cells and (I) CD8+ T cells from spleen; (J) CD4+ and (K)
CD8+ T cells from mesenteric lymph node; and (L) CD4+ and (M) CD8+ T cells from Peyer’s patch. Cells from IEL in small intestine were detected
for GFP. (N) CD8ab cells, (O) CD8aa cells, (P) TCRgd cells, and (Q) TCRabwere gated to detect GFP. Mean and SD is shown as ‘‘mean6 SD.’’ The
data shown are typical results of more than five experiments.
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tiger mice and control mice were injected with anti-CD3 three times. 4 hr after the last injection, mice were sacrificed and the GFP expression
of IEL and LPL from small intestine and colon were analyzed.
(A, E, and H) Distribution of CD4+ cells, CD8+ cells, and CD4+CD8+ double-positive cells in TCRab+ population in sIEL, sLPL, and cLPL, respec-
tively. The gates shown in these panels were used for the following analysis of GFP expressions.
(B–D) GFP expression of (B) CD8+, (C) CD4CD8 double-positive, (D) CD4+ TCRab+ IEL from small intestine.
(F and G) GFP expression of (F) CD8+ and (G) CD4+ TCRab+ cells from LPL from small intestine.
(I and J) GFP expression of (I) CD8+ and (J) CD4+ LPL from colon. Mean and SD is shown as ‘‘mean6 SD.’’ The data shown are typical results of
three experimentsw75% of sLPL T cells were CD4+ (Figure 4E) and the re-
mainder CD8+. In the small intestine, a high percentage
of CD8+ sIEL were GFP+ as described above (Figure 4B).
In contrast, GFP expression in CD4+ T cells from the LPL
population was much lower compared to that of IEL both
in cell count and intensity (Figure 4G). CD8+ cells and
CD4+ cells represent the major T cell population in IEL
and LPL, respectively, so the comparison of IEL and
LPL TCRab T cells gives a very different pattern of GFP
expression. When we repeated these experiments with
sIEL and sLPL from the same mice at the same time point
to eliminate variability (data not shown), we obtained the
same results, confirming that this difference is not be-
cause of the lengthy procedure required to collect sLPL.
In this experiment, minor populations such as CD4+ cells
in IEL and CD8+ cells in LPL were also found to have var-
ious amounts of GFP+ cells (Figures 4C, 4D, and 4F).
We also observed GFP expression in the large intes-
tine after three in vivo stimulations with anti-CD3, but
the cell types involved were different from that observedfor the small intestine. Interestingly, a high frequency
of CD4+ cells, which represent the major population in
LPL, were GFP+ (Figure 4J). The minor CD8+ T cell pop-
ulation was also GFP+ in the LPL compartment (Fig-
ure 4I). However, GFP expression of the IEL from the
colon was similar to the small intestine (data not shown).
These results suggest that the colon is a distinct immu-
nologic environment from the small intestine, especially
with regard to LPL. GFP-expressing cells were rarely
found in control or unstimulated mice (Figure 5K), so
IL-10 expression is inducible, being upregulated in this
case.
Anti-CD3 Induces Tr1-like Cells in sIEL-
and Foxp3-Positive Cells in cLPL
To further characterize the IL-10-positive cells in the in-
testine, we examined the expression of other cytokines
and Foxp3. First, to confirm that IL-10 protein expres-
sion correlated with GFP expression in IEL, we stained
intracellular IL-10. As shown in Figure 5A, there was
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Mice
After three anti-CD3 injections, TCRab+ cell in sIEL (A–C) and cLPL (D–F) were collected and analyzed for (A, D) IL-10, (B) IFN-g, and (C, E) IL-4.
Horizontal axis shows the GFP expression of these cells. (F) CTLA-4 protein in CD4+TCRab+ cells detected by intracellular staining.
(G and H) After three anti-CD3 injections, (G) splenic CD4+ cells and (H) colon CD4+ LPL cells of TCRab+ cells were stained with anti-CD25 and
further stained intracellularly with anti-Foxp3 and detected with FACS.
(I) The percentage of Foxp3+ cells within CD4+ cells from cLPL and spleen in anti-CD3-treated and control (PBS-injected) mice. White bars
represent the percentages of Foxp3+ cells within CD4+TCRab+ cells in spleen cells, and black bars represent those in colonic LPL cells. The error
bars show the standard deviation.
(J) The total number of Foxp3+ CD4+ T cells obtained from mice unstimulated and stimulated with anti-CD3. The data shown are representative of
more than six similar results. The error bars show the standard deviation.
(K) FIR 3 tiger mice were treated with PBS (control) or anti-CD3 three times, and the cells were collected from spleen, mesenteric lymph nodes
(MLN), IEL from the small intestine (sIEL), and LPL from the colon (cLPL). The cells from spleen, MesLN, sIEL, and cLPL are the gated population
of TCRab+CD4+ cells and sIEL are gated for TCRab+ cells. The data shown are representative of more than three similar experiments.again a positive association of IL-10 production and
GFP expression, similar to the results obtained with
Th2 cells developed in vitro. In this experiment, we
also stained for IFN-g and IL-4, but there were few pos-
itive cells (Figures 5B and 5C), suggesting that these
GFP+ cells are not Th2- or Th1-like cells but more char-
acteristic of Tr1 cells, which produce only IL-10. We
stained intracellular foxp3 protein, but in IEL from the
small intestine less than 1% of TCRab+ cells were posi-
tive for Foxp3, and therefore do not have the character-
istics of nTreg cells.
In colonic LPL cells, we also performed intracellular
cytokine and Foxp3 detection. Similar to the results of
IEL in small intestine, the IL-10 protein expression of co-
lonic LPL were confirmed to correlate with GFP expres-
sion (Figure 5D), and IL-4 (Figure 5E) and other cytokines
like IL-2 and IFN-g (data not shown) were undetectable.Interestingly, these colonic LPL expressed CTLA4 after
repetitive anti-CD3 stimulation (Figure 5F), and the num-
ber of colonic CD25+ Foxp3-expressing cells increased
(Figures 5H–5J), although there was no major change in
the nTreg cell number in spleen after anti-CD3 treatment
(Figures 5G and 5I). To determine whether cell prolifera-
tion contributes to this accumulation of nTreg cells in
cLPL, we administered BrdU in the drinking water during
the anti-CD3 treatment and stained the cLPL with BrdU
antibody. CD4+CD25+ T cells in cLPL proliferated in con-
trast to splenic CD25+ T cells, which did not (Figure S2).
This result suggests that the increased number of Treg
cells in cLPL is dependent on proliferation of nTreg cells,
at least to some extent.
The high GFP expression in colonic LPL seemed to be
associated with the accumulation of nTreg cells at that
site, which strongly suggested that these nTreg cells
Immunity
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relationship between IL-10-expressing cells and
Foxp3-expressing nTreg cells, we crossed the Foxp3-
IRES-mRFP (FIR) reporter mouse (Wan and Flavell,
2005) and the tiger mouse. The results obtained from
the cells from control and anti-CD3-stimulated mice
are shown in Figure 5K. In spleen and mesenteric lymph
nodes, less than 3% of the cells were positive for GFP in
control mice, and both in Foxp3-expressing and -nonex-
pressing cells were GFP+. After several injections of
anti-CD3, we observed an increase of GFP positivity in
both Foxp3+ and Foxp32 cells.
In sIEL TCRab+ cells, there were few Foxp3 cells, and
the GFP+ cells induced after anti-CD3 injection was
mostly in the Foxp32 population, confirming that Tr1-
like cells arise after anti-CD3 stimulation. In contrast,
in cLPL cells, the number of Foxp3+ cells increased after
anti-CD3 treatment and the GFP-expressing cells were
mainly observed in the RFP+ (Foxp3+) population. There
were also a substantial number of RFP(Foxp3)-negative
GFP+ cells, suggesting that some Tr1-like cells arise in
cLPL after anti-CD3 injection.
To summarize, repetitive anti-CD3 treatment induces
Tr1-like cells in IEL of the small intestine, whereas the
sametreatment inducesmostlynTregcells in LPL incolon.
CD4+ T Cells Adoptively Transferred to RAG-
Deficient Mice Differentiate to IL-10-Expressing Cells
in the Intestine
Our experiments suggested that IEL in the small intes-
tine are committed to producing IL-10. This high IL-10
production from IEL might be acquired as a conse-
quence of being a specific IEL lineage or may result
from the ability of the gut surrounding the IEL to provide
a special environment, causing them to differentiate into
IL-10-producing cells.
To elucidate the importance of the gut environment for
T cells to develop into IL-10-producing cells, we investi-
gated whether conventional CD4+ cells from the spleen
can differentiate into IEL-like IL-10-producing cells
when transferred into immunodeficient RAG knockout
mice, which would lead to colonization of the gut. 2
months after transfer of splenic CD4+ cells to RAG-defi-
cient mice, we recovered splenocytes and IEL and
scored the GFP signal by flow cytometry 4 hr after a sin-
gle stimulation with anti-CD3. As shown in Figure 6D,
splenic T cells did not express much GFP, whereas
again, IEL had a higher percentage of GFP+ cells (Fig-
ures 6B and 6C). It has been reported that CD4+ cells
enter the IEL compartment and acquire CD8 on their sur-
face when transferred to RAG-deficient mice (Das et al.,
2003). We were able to reproduce that observation
(Figure 6A) and found that a high percentage of both
CD4 single-positive (Figure 6B) and CD4+CD8+ double-
positive (Figure 6D) cells were GFP+, with a higher per-
centage of GFP+ cells in the CD4+CD8+ double-positive
population. It was noteworthy that only one injection of
anti-CD3 was sufficient to induce measurable GFP ex-
pression, a strikingly different result from that which we
obtained with the nontransfer model; i.e., the steady-
state situation in the tiger mouse. To summarize, con-
ventional T cells can differentiate into IL-10-expressing
cells when transferred into immunodeficient hosts, but
this occurs selectively in the intestinal environment.Requirement of Fc Receptor Binding of Anti-CD3 to
Generate IL-10-Producing T Cells in sIEL and cLPL
The generation of IL-10-expressing cells in the intestine
might depend on the ability of the anti-CD3 to bind to
other accessory cells and crosslink the TCR signaling
component. To address this issue, we injected anti-
CD3 engineered to lower the binding activity to Fc re-
ceptor (anti-CD3-IgG3) (Alegre et al., 1995). When we
detected GFP+ cells after three injections of anti-CD3-
IgG3, there was no increase of GFP+ cells in sIEL nor
in cLPL (Figures 6E and 6F). Likewise, there was no in-
crease of Foxp3+ cells after the injection of this antibody
(Figure 6G). Thus, the increase of GFP+ cells by the injec-
tion of anti-CD3 depends on the Fc binding ability and
mitogenic activity of this antibody.
Expression of GFP in the tiger Reporter Mouse after
Salmonella and Leishmania Infection
The tiger system can be used to study IL-10 expression
in a number of settings such as during microbial
Figure 6. CD4+ T Cells Acquire a GFP+ IEL-like Phenotype when
Transferred to RAG-Deficient Mice, and Mitogenic Ability of Anti-
CD3 Is Required to Induce IL-10-Expressing IEL and cLPL
CD4+ T cells were derived from tiger or control mice and adoptively
transferred to RAG-deficient mice. 2 months after the transfer, mice
were injected with anti-CD3 and sacrificed 4 hr after injection. The
splenocytes and IEL from small intestine were collected and
analyzed for GFP.
(A–C) CD4 versus CD8 staining profile of TCRab+ IEL (A), and the
gates used in (B) and (C). The GFP expression of (B) CD4+CD8+
double-positive IEL and (C) CD4+ IEL are shown.
(D) GFP expression of CD4+TCRab+ T cells from spleen.
(E–G) Anti-CD3, anti-CD3-IgG3, or PBS was injected to the tiger
mice and control mice three times every third day, and the IEL and
LPL were corrected to detect GFP (E, F) and Foxp3 expression
(G). Foxp3 was detected by intracellular staining followed by FACS
detection. Percentage of GFP+ cells in TCRab+ cells in sIEL, CD4+
cLPL, and Foxp3+ from CD4+ cLPL are shown. The experiments
were repeated for three times with similar results. The error bars
show the standard deviation.
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949infection. We therefore infected tiger reporter mice with
Salmonella typhimurium, enteropathogenic bacteria
that is known to induce profuse inflammation in the intes-
tinal tract. 2 and 5 days after infection, mice were sacri-
ficed, and the presence of GFP-producing cells in the
intestine, spleen, and mesenteric lymphnodes were in-
vestigated as indicated in Experimental Procedures. 2
days after bacterial infection, no GFP-producing cells
were detected among Peyer’s patches cells, sIEL,
cLPL, intestinal epithelial cells, splenic T or B cells, or
macrophages. 5 days after infection, modest number of
GFP-expressing cells were detected among cLPL, the
majority of which were CD25+ T cells (Figures 7A and 7B).
As a model of macrophage infection and the induction
of IL-10-producing cells in parasitic infection, we used L.
major. 28 days after footpad infection with L. major, the
mice were sacrificed and examined for GFP expression.
We first analyzed the draining popliteal lymph node and
found only few GFP+ T cells and no GFP+ macrophages
(Figure 7C). When we isolated lymphocytes from the in-
flamed footpad tissue, we could detect more GFP+ CD4
T cells (Figure 7D). There appeared to be an increase in
GFP expression in the previously GFP2 cell population
as well as a second population of GFPhi cells (Figure 7D).
More than 70% of these GFPhi cells were CD25+ by dot
plot analysis, suggesting that these cells may be nTreg
cells (data not shown). Macrophages and CD11c+ cells
from the infected tissue were again negative for GFP.
Discussion
The generation of the tigermouse enables the identifica-
tion of cells committed to produce IL-10. In this report,
we have found this model to be useful in identifying cells
producing IL-10, especially in vivo. The advantage of
this reporter mouse is the ability to combine GFP analy-
sis with multicolor staining with other antibodies, which
enabled us to perform a detailed analysis of IL-10-pro-
ducing populations.
Because the GFP gene was knocked in to the 30 end of
the IL-10 gene downstream of the 30-UTR, its expression
should reflect IL-10 mRNA expression. From our find-
ings, GFP expression was positively associated with
IL-10 protein expression. In the same experiments, we
also found a small GFP-positive, IL-10-negative popula-
tion. This difference may be due to a possible posttran-
scriptional or translational regulatory mechanism or
because GFP is inherently more stable than IL-10 protein
and may persist longer in cells. Because we find that the
IL-10 amount is roughly proportional to GFP expression,
we think that, in the tiger mouse, the GFP expression
fairly reports the production of IL-10 and with higher sen-
sitivity than intracellular staining. However, caution must
be exerted in the interpretation of results with these
mice, because essentially we report IL-10 mRNA and
translational control of IL-10 mRNA will not be reported
in this model. Furthermore, the result might differ de-
pending on the location of insertion of the reporter
gene within the IL-10 locus and whether an IRES se-
quence was used or not. Future use of our system might
be helpful in identifying posttranscriptional regulatory
mechanisms by staining for IL-10 together with GFP in
combination with other stimuli that might potentially
affect this posttranscriptional regulation.Our data show that IL-10 expression is not strictly
monoallelic, because more than 60% of CD4+ T cells
were positive for GFP when cells were cultured under
Th2 conditions. This observation is congruent with the
results from the very similar 4GET IL-4 knockin mice,
where more than 60% of the cells were positive for
GFP under Th2 conditions (Mohrs et al., 2005).
After multiple rounds of TCR (CD3 antibody: 145-2C11)
or superantigen stimulation in vivo, T cells produced
IL-10 as revealed by increased GFP as well as IL-10 pro-
tein expression. This result suggests that T cells might
differentiate into IL-10-producing cells after several
cycles of TCR stimulation.
Stimulating T cells multiple times in vivo has been
known previously to induce high IL-10 in serum, but the
major source of IL-10 has never been clear (Sundstedt
et al., 1997). It might logically have been expected that
T cells in spleen and lymph nodes might be the major
source, but our results suggest that gut IEL may be
most important, particularly given the fact that the IEL
are the largest T cell population in the body. It is possible
that other disease models that also exhibit high serum IL-
10 might have similarly high IL-10 expression by gut IEL.
Further analysis is necessary to elucidate the relation-
ship between the suppressive IL-10-expressing T cells
induced by TCR stimuli and the intestinal lymphocytes.
From our measurements of Foxp3 and intracellular cy-
tokine staining, it was suggested that sIEL and cLPL are
fundamentally different cell types although they both
Figure 7. GFP Expression of T Cells after S. typhimurium and
L. major
(A and B) GFP knockin mice were infected with 105 ofS. typhimurium
per oral and sacrificed after 5 days. The LPL from colon were pre-
pared from (A) noninfected and (B) infected mice.
(C and D) The isolated cells were gated for CD4+TCRb+ and plotted.
The results obtained from L. major infection are shown in (C) and (D).
GFP knockin mice or control mice were infected with L. major for 28
days. The CD4+TCRb+ lymphocytes from (C) popliteal lymph nodes
and (D) footpads were isolated and subjected to FACS analysis.
Dotted line represents GFP2 control cells and solid line represents
cells from tiger mice. Experiments were repeated twice with 3–5
mice per group and similar results were obtained.
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cytokines like IL-2, IL-4, and IFN-g. One important ques-
tion would be whether these IL-10-producing cells de-
veloped in situ and expanded in number locally or alter-
natively migrated from other sites and acquired IL-10
production. In the case of sIEL, both TCRab and gd T
cells were shown to be GFP+ after stimulation, with the
higher percentage of GFP+ cells being TCRab cells.
When we compared CD8aa and CD8ab TCRab T cells,
we found that a higher percentage of CD8ab cells pro-
duced GFP. CD8ab is characteristic of conventional T
cells, so it might be that conventional T cells migrate
from outside the IEL compartment and differentiate
there into IL-10-producing cells. This idea is consistent
with the fact that the profiles of CD4, CD8, and CD103
expression changes after anti-CD3 injection and
showed an increased number of CD4+ T cells and
CD8abCD1032 T cells (M.K., R.A.F., unpublished data),
which suggests the mobilization of conventional T cells
into IEL compartment.
In the case of nTreg cells in cLPL, they might derive
from existing nTreg in cLPL or be recruited from other
tissue sites or peripheral blood. Because the number
of Treg cells increased after TCR stimulation, the in-
creased ratio of GFP+ cells does not seem to be the re-
sult of the deletion of GFP2 cells but rather proliferation
of cLPL. It is, however, also possible that migrating cells
from other sites might contribute to increase the number
of nTreg cells in cLPL. Further work will be required to
elucidate this.
As shown in our results, there was some variability in
the frequency (40%–70%) and number of nTreg cells in-
duced after anti-CD3 stimulation. This might be caused
by genetic factors or environmental factors like com-
mensal bacteria. However, we consistently observed in-
duction of GFP+ Treg cells in cLPL in more than eight
experiments with littermates as controls for genetic
variability.
From our observations, it appears that intestinal lym-
phocytes are strongly committed to IL-10 production,
which is markedly different from what is seen with con-
ventional T cells. Such a difference in phenotype might
be a consequence of the special environment in the gut
where specific factors may influence the differentiation
of T cells. This possibility was confirmed by adoptive
transfer of CD4+ cells to RAG-deficient mice, which
showed that conventional T cells can differentiate into
IL-10-producing IEL-like cells but not into IL-10 pro-
ducers in the spleen. The identity of the molecule(s)
that are required for upregulation of IL-10 needs to be
elucidated in future studies.
The repetitive administration of anti-CD3 has been
found to be an effective therapy for type I diabetes
(T1D) (Chatenoud et al., 1994) and graft-versus-host dis-
ease (GVHD) (Nicolls et al., 1993). The phenomenon that
repetitive stimulation of anti-CD3 induces gut IEL cells to
express IL-10 might not occur in patients treated with
this therapy because the nonmitogenic CD3 antibody is
now used for clinical trials in humans, and at least the
murine nonmitogenic anti-CD3 did not induce Tr1-like
cells in IEL nor nTreg cells in cLPL in tiger mice in our
experiments. However, the antibodies used in the human
trials probably retain residual Fc binding ability because
some symptoms like fever and rash, which suggest mito-genic activity for this antibody, happens frequently in
patients treated with this therapy. It is, therefore, still
not completely ruled out that the nonmitogenic anti-
CD3 might act on intestinal lymphocytes to induce sup-
pressive cells.
We attempted to detect GFP positivity in cell types
other than T cells, but we could not identify strong sig-
nals in macrophages, B cells, or dendritic cells in vivo.
All these cells have been reported to produce IL-10
in vitro, but our reporter mouse might not be sensitive
enough to detect low amounts of IL-10 production.
Despite single or multiple rounds of stimulation with
LPS (100 mg 3 times) in vivo, no induction of GFP was
observed 6–24 hr poststimulation. The dose we used
in vivo might not be enough to maintain the concentra-
tion used in vitro.
We could detect IL-10 production in myeloid cells
in vitro. As shown in the in vitro culture experiments,
however, the GFP expression of non-T cells is still not
high as that of T cells. This might result from different
IL-10 regulatory mechanisms in distinct cell types. Be-
cause the GFP expression relative to IL-10 staining
was relatively low in dendritic cells, the mRNA expres-
sion of IL-10 might be low but translation of IL-10 might
be more efficient per given mRNA molecule in DC than
T cells. This is in line with the fact that the IL-10 protein
expression is much less in myeloid cells compared to
T cells.
The GFP expression of dendritic cells ex vivo was less
than in vitro stimulated BMDC. We currently do not know
why this is so. As reported by others (Edwards et al.,
2002), additional stimuli such as CD40L might be neces-
sary to detect IL-10 expression in dendritic cells derived
ex vivo. Further analysis in the future will be necessary to
study the mechanism underlying the differences of IL-10
production in T and non-T cells.
We infected tiger mice with S. typhimurium and
L. major to examine IL-10 production during microbial
infection. We found modest increase in the number of
GFP-expressing cells 120 hr after inoculation, which is
the time of maximal intestinal inflammation in this model
of infection. This finding is in line with the notion that
IL-10 can be induced during chronic inflammation. It is
possible that the strong inflammatory response could
result in the induction of nTreg cells in the inflamed colon
as the GFP+ cells in cLPL were mostly CD25+ T cells.
Leishmania infection is a model of macrophage infec-
tion that leads to the induction of Th1 cells in C57BL/6
mice and Th2 cells in Balb/c mice, which are responsible
for the resistance and susceptibility of these strains, re-
spectively. During Leishmania infection of tiger mice,
GFP induction was found in the T cells isolated from
the inflammatory tissue but not from draining lymph
nodes. These findings suggest a more important role of
IL-10 in the inflammatory tissue than in secondary lym-
phoid organs like lymph nodes. More importantly, in
the present context, they show the potential utility of
the tiger system in this kind of study.
In conclusion, we have developed a system to detect
and monitor cells committed to IL-10 production. IL-10
production was preferentially observed in some popula-
tions of intestinal tissue. Further analysis of how IL-10
expression is obtained in mucosal organs might in turn
lead to a better understanding of the suppression
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long term, lead to new approaches to the therapy of in-
flammatory bowel disease as well as vaccine develop-
ment through the mucosal route. We anticipate that
the tiger mouse will facilitate the further study of IL-10
biology.
Experimental Procedures
Generation of tiger Mice
A 5.8 kb HindIII genomic fragment containing the polyadenylation
signal of exon 5 of the IL10 locus was cloned into the HindIII site
of the pEasyFlox vector. The BglII-BamH1 fragment and IRES-GFP
cassette was isolated from the pMSCV GFP vector and cloned
into the BamH1 site of pEasyFlox. With Not1 sites introduced on ei-
ther end, a 3.8 kb fragment spanning intron 1 through the 30 untrans-
lated region of exon 5 of the IL10 gene was then inserted into the
modified pEasyFlox vector via Not1 sites. The linearized vector
was electroporated into TC1 embryonic stem (ES) cells. G418-resis-
tant, gancyclovir-sensitive clones were screened by Southern blot,
and selected clones were subsequently transfected with Cre recom-
binase for neo deletion. Successfully targeted clones were injected
into C57BL/6 blastocysts. Chimeric males in which germline trans-
mission was successful were bred to C57BL/6 mice. FIR mice
(Wan and Flavell, 2005) were screened by PCR and used to cross
with tiger mice for the analysis. All mouse experiments were
approved by Institutional Animal Care and Use Committee of Yale
University.
Th1, Th2 Differentiation In Vitro
5–153 104 of CD4+ T cells purified with MACS (Miltenyi) and 53 106
of APCs (3000 rad irradiated splenocytes) were cocultured with anti-
CD3 (145-2C11, ATCC) and anti-CD28 in medium (Bruff’s supple-
mented with 10% FCS, L-glutamine, penicillin, and streptomycin)
for times indicated under Th0, Th1 (IL12 plus anti-IL4), or Th2 (IL4
plus anti-IFNg) conditions (IL12 was a generous gift of Wyeth).
Supernatants from these cultures were collected and ELISA was
performed.
For intracellular cytokine staining, the cells were washed once and
restimulated with PMA (Sigma, 2 ng/ml) and ionomycin (Sigma, 2
mg/ml) for 4 hr. Golgistop (BD, USA) was added during the last 2 hr
of restimulation. Intracellular cytokine staining was performed ac-
cording to the manufacturer’s instruction, and the cells were de-
tected for cytokine and GFP on a FACS Calibur instrument (BD,
USA). Anti-IL-2, anti-IL-4, anti-IL-10, and anti-IFN-g for intracellular
cytokine staining were purchased from BD, USA. The anti-Foxp3
intracellular staining kit was purchased from eBioscience, USA.
For quantitative PCR, RNA was extracted with TRIzol reagent and
cDNA was synthesized by Superscript II reverse-transcriptase
according to the manufacturer’s protocols (Invitrogen). The ABI
7500 Real-Time PCR system was used for quantitative PCR with
primer-probe sets purchased from ABI.
Generation of Bone Marrow-Derived Macrophages
and Dendritic Cells
Bone marrow was obtained by flushing tibia and femur with DMEM
(Invitrogen). The medium was DMEM supplemented with 20% FCS,
glutamine (both from Invitrogen), and, to generate BMDM, 30% L929
supernatant containing macrophage-stimulating factor. Bone
marrow cells were cultured for 5 days. Cells were harvested with
cold dPBS (Invitrogen), washed, and resuspended in DMEM supple-
mented with 10% FCS.
To obtain dendritic cells, bone marrow cells were cultured in 3%
L929 supernatant containing GM-CSF. Fresh medium was added
every 2 days. After 5 days, medium alone or LPS (500 ng/ml), zymo-
san (50 mg/ml, Sigma), TGF-b (2 ng/ml), and IL-4 (2500 U/ml) were
added to the culture, and GFP expression was detected 24 hr later.
Dendritic cells from the spleen and Peyer’s patch were isolated as
reported previously (Iwasaki and Kelsall, 1999).
In Vivo Stimulation of T Cells and Isolation of Lymphocytes
tiger mice and control littermates were injected with 20 mg of anti-
CD3 (145 2C11) or nonmitogenic anti-CD3 IgG3 (Alegre et al.,1995) i.p. Alternatively, tiger mice crossed to AND TCR Tg mice
(Jackson Laboratory, USA) were injected with 5 mg of SEA (Toxin
technology, USA) i.p. 1–3 times with an interval of 2 days and sacri-
ficed 4 hr after final injection. For the controls, PBS were injected.
The IEL and LPL were collected as described with some modifica-
tions (Das et al., 2003). In brief, small or large intestine was washed
with Hank’s Buffered Saline and incubated in the presence of 5 mM
of EDTA at 37C for 30 min. The released cells were loaded onto
a Percoll gradient and centrifuged. The cells between 44% and
67% Percoll were collected and used as intestinal epithelial cells.
LPL were collected by digesting gut tissue, which was removed
for IEL isolation as described above. The tissue was digested with
collagenase IV (100 U, Sigma) at 37C for 1 hr and loaded onto
a Percoll gradient and centrifuged. The cells between 40% and
100% Percoll were collected and used as LPL.
Adoptive Transfer of CD4+ T Cells
CD4+ T cells from splenocytes were collected from tiger mice and
their control wild-type mice by MACS (Miltenyi). 106 CD4+ T cells
were intravenously injected into Rag12/2 mice (Jackson). 1 month
later, the mice were injected with 10 mg of anti-CD3 i.p. and the IEL
were recovered and examined for GFP by FACS.
Infection with S. typhimurium and L. major
S. typhimurium infections of streptomycin-treated mice were carried
out as previously described (Lara-Tejero et al., 2006). Mice utilized in
these studies were confirmed to be nramp1 (Slc11a1)2/2 and there-
fore of the ‘‘Salmonella-susceptible’’ genotype. In brief, mice were
pretreated with 20 mg streptomycin 24 hr prior to oral inoculation
with either 108 or 105 c.f.u. of wild-type S. typhimuium strain
SL1344 and sacrificed 2 and 5 days after inoculation, respectively.
The lymphocytes from colon Lamina propria, IEL from small intes-
tine, lymphocytes from spleen, mesenteric lymph nodes, and
Peyer’s patches were recovered and examined for GFP expression
by FACS.
For infection study with Leishmania, mice were injected in the hind
footpad with 1.5 3 106 stationary-phase L. major (WHO MHOM/IL/
80/Friedlin) promastigotes and were sacrificed 28 days after infec-
tion. Lymphocytes from draining lymph nodes and footpad tissue
was recovered and examined for GFP by FACS. To recover lympho-
cytes from the footpad tissue, tissue was minced and digested
with 200 U/ml collagenase IV (Sigma, USA) in DMEM with 10%
FCS for 2 hr, and live cells were recovered by step gradient centrifu-
gation with Ficoll (LSM Lymphocyte Separation Medium, MP
Biomedicals, OH).
Supplemental Data
Three Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/6/941/DC1/.
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